Akums reports robust Q1 FY27 performance with 13.9% YoY Revenue growth
Limited reporting45New Delhi,11th August 2026: Akums Drugs and Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organization (CDMO), announced its consolidated financial results for the quarter ended June 30, 2026, marking a strong start to FY27. The Company delivered healthy growth in r...
First seen · latest update · India · business
- Indian mainstream 0
- Indian independent 1
- International 0
- Official 0
See a mistake? Wrong summary · Wrongly grouped · Missing source · Wrong category/region · Dispute outlet rating — each opens a pre-filled report on GitHub.